- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07831018
Impact of AI Care Summaries on Caregiver Comprehension
Impact of AI Care Summaries on Caregiver Comprehension of Hospital Course
The primary objective is to assess if an AI-generated plain language summary of an inpatient progress note can improve caregiver understanding of their child's hospitalization by measuring differences in Hospital Course Comprehension scores, based on their responses to a survey regarding their child's hospital course.
Secondary objectives include exploring the caregiver's perspective on the use of AI in clinical care, as well as 7-day and 30-day readmission rates, 7-day and 30-day emergency department (ED) re-utilization rates, length of stay, and environmental impact measures.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
This randomized controlled trial evaluates whether AI-generated plain-language summaries of inpatient progress notes improve caregiver understanding of a child's hospitalization. The intervention uses a Children's National HIPAA-compliant large language model hosted within the institution's Azure environment to generate caregiver-facing summaries from attending-signed inpatient progress notes.
Eligible caregivers are randomized to receive either standard hospital communication alone or standard communication plus an attending-approved AI-generated care summary. Before distribution to caregivers, attending physicians review generated summaries for clinical appropriateness and accuracy.
Caregiver understanding of the hospitalization is assessed using a structured survey administered during the hospitalization. Responses are compared with information documented in the medical record to evaluate comprehension. Additional exploratory analyses evaluate implementation outcomes, caregiver perceptions of AI-assisted communication, physician acceptance of generated summaries, healthcare utilization outcomes following hospitalization, and operational measures related to AI summary generation.
Statistical analyses will compare outcomes between randomized groups while controlling for relevant covariates when appropriate.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Kristen E Johnson, MD, MS
- Telefoonnummer: 571-235-6524
- E-mail: kejohnson@childrensnational.org
Studie Locaties
-
-
District of Columbia
-
Washington D.C., District of Columbia, Verenigde Staten, 20010
- Werving
- Children's National Hospital
-
Contact:
- Kristen Johnson, MD, MS
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria: Caregiver of a patient 10 years and younger admitted to Children's National Hospital, whose preferred language is English
Exclusion Criteria:
- Caregivers of patients older than age 10 years
- Caregivers of patients not admitted to the Hospital Medicine service
- Caregivers of admitted patients whose preferred language is non-English
- Patients whose care summaries are deemed inaccurate by their attending physician and not eligible for sharing with their caregiver.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Standard Hospital Communication
Standard hospital communication |
|
|
Experimenteel: Standard Hospital Communication Plus AI Care Summary
Attending-approved written AI Care Summary provided to caregiver |
Written AI-generated plain-language summary of the patient's hospital course, reviewed and approved by the attending physician and provided to the caregiver during the hospitalization. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Hospital Course Comprehension Score
Tijdsspanne: Within 24 hours after receipt of the AI care summary or completion of standard care communication, during the index hospitalization
|
Percentage of caregiver survey responses that align with information documented in the medical record (range 0%-100%; higher scores indicate greater caregiver understanding of the hospital course). |
Within 24 hours after receipt of the AI care summary or completion of standard care communication, during the index hospitalization
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
LOS
Tijdsspanne: Throughout study duration, on average one year
|
Length of stay |
Throughout study duration, on average one year
|
|
Readmission
Tijdsspanne: During study duration, on average one year
|
7-day and 30-day readmission rates: readmissions within 7 or 30 days of the index hospitalization, when related to problems addressed during the initial hospitalization. |
During study duration, on average one year
|
|
ED reutilization
Tijdsspanne: 7 days after index hospital discharge and 30 days after index hospital discharge, respectively
|
7-day and 30-day ED re-utilization rates: return visits to the emergency department within 7 or 30 days for complaints related to the initial hospitalization. |
7 days after index hospital discharge and 30 days after index hospital discharge, respectively
|
|
Tokens
Tijdsspanne: WIthin 1 hour following generation of each AI care summary (during index hospitalization)
|
Token burden: the number of tokens used per AI-generated care summary. |
WIthin 1 hour following generation of each AI care summary (during index hospitalization)
|
|
Energy usage
Tijdsspanne: WIthin 1 hour of generation of the AI care summary (during index hospitalization)
|
Energy use: estimated average kilowatt-hour use per AI-generated summary. |
WIthin 1 hour of generation of the AI care summary (during index hospitalization)
|
|
Acceptability: Physician
Tijdsspanne: Within 1 hour of attending physician review of each AI-generated summary, prior to caregiver distribution, during index hospitalization
|
AI care summary rejection rate: the proportion of AI-generated summaries that attending physicians determine are not appropriate to share with caregivers. |
Within 1 hour of attending physician review of each AI-generated summary, prior to caregiver distribution, during index hospitalization
|
|
Reason for Rejection
Tijdsspanne: WIthin 1 hour of attending physician review of the AI care summary, during the index hospitalization
|
Reason for rejection: the primary reason an attending rejects a summary. One of five categorical options for rejection (contains sensitive information, contains factual errors, tone is not right, prefer not to provide written information, concerned may cause confusion); or category "other" with a free text response. |
WIthin 1 hour of attending physician review of the AI care summary, during the index hospitalization
|
|
Caregiver-Rated Usefulness of AI Care Summary (5-Point Likert Scale)
Tijdsspanne: Within 24 hours after receipt of the AI care summary, during the index hospitalization
|
Caregiver rating of how helpful the AI-generated care summary was for understanding the child's hospitalization, measured on a 5-point Likert scale ranging from 1 (Not Helpful at All) to 5 (Extremely Helpful). Higher scores indicate greater perceived usefulness. |
Within 24 hours after receipt of the AI care summary, during the index hospitalization
|
|
Engagement: Caregiver
Tijdsspanne: Within 24 hours after receipt of the AI care summary, during the index hospitalization
|
Caregiver interest in AI summaries as standard care: whether caregivers would want this type of summary incorporated into routine care. |
Within 24 hours after receipt of the AI care summary, during the index hospitalization
|
Medewerkers en onderzoekers
Publicaties en nuttige links
Algemene publicaties
- Greenberg JA, Basapur S, Quinn TV, Bulger JL, Schwartz NH, Oh SK, Ritz EM, Glover CM, Shah RC. Daily Written Care Summaries for Families of Critically Ill Patients: A Randomized Controlled Trial. Crit Care Med. 2022 Sep 1;50(9):1296-1305. doi: 10.1097/CCM.0000000000005583. Epub 2022 May 23.
- Bedi S, Liu Y, Orr-Ewing L, Dash D, Koyejo S, Callahan A, Fries JA, Wornow M, Swaminathan A, Lehmann LS, Hong HJ, Kashyap M, Chaurasia AR, Shah NR, Singh K, Tazbaz T, Milstein A, Pfeffer MA, Shah NH. Testing and Evaluation of Health Care Applications of Large Language Models: A Systematic Review. JAMA. 2025 Jan 28;333(4):319-328. doi: 10.1001/jama.2024.21700.
- Schoonbeek RC, Workum JD, Schuit SCE, Hoekman AH, Mehri T, Doornberg JN, van der Laan TP, Bootsma-Robroeks CMHHT; Applied Artificial Intelligence in Healthcare Consortium. Quality and efficiency of integrating customised large language model-generated summaries versus physician-written summaries: a validation study. BMJ Open. 2025 Sep 4;15(9):e099301. doi: 10.1136/bmjopen-2025-099301.
- Johnson AM, Brimhall AS, Johnson ET, Hodgson J, Didericksen K, Pye J, Harmon GJC, Sewell KB. A systematic review of the effectiveness of patient education through patient portals. JAMIA Open. 2023 Jan 18;6(1):ooac085. doi: 10.1093/jamiaopen/ooac085. eCollection 2023 Apr.
- Rea KE, Rao P, Hill E, Saylor KM, Cousino MK. Families' Experiences With Pediatric Family-Centered Rounds: A Systematic Review. Pediatrics. 2018 Mar;141(3):e20171883. doi: 10.1542/peds.2017-1883. Epub 2018 Feb 6.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- STUDY00001841
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Our IRB protocol does not permit IPD sharing for subject privacy
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .